ClassID:

94285

C07D215/50 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Sub-classes:
Recent Application in this class:
#1
20260152493
2026-06-04

INHIBITORS OF SARM1

#2
20250368607
2025-12-04

QUINOLINEAMINE ANTIDEGRADANT COMPOUNDS AND USES THEREOF

#3
20250064060
2025-02-27

BIS(HETERO)ARYL THIOETHER (THIO)AMIDES AS FUNGICIDAL COMPOUNDS

#4
20240343709
2024-10-17

SUBSTITUTED HETEROCYCLES AS ALDEHYDE DEHYDROGENASE INHIBITORS

#5
20240228432
2024-07-11

Sirtuin modulating compounds and applications thereof

#6
20240228431
2024-07-11

SIRTUIN MODULATING COMPOUNDS AND APPLICATIONS THEREOF

#7
20240180916
2024-06-06

Theramutein modultors

#8
20240132469
2024-04-25

Substituted heterocycles as aldehyde dehydrogenase inhibitors

#9
20240059656
2024-02-22

A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN

#10
20240002332
2024-01-04

Small Molecule Inhibitors of SARS-CoV-2 Infections

#11
20230295094
2023-09-21

NITROXOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#12
20220370469
2022-11-24

Theramutein modulators

#13
20220362257
2022-11-17

Theramutein modulators

#14
20220315568
2022-10-06

INHIBITORS OF SARM1

#15
20220047572
2022-02-17

Therapeutic agent for fibrosis

#16
20210015825
2021-01-21

Theramutein modulators

#17
20210008077
2021-01-14

Theramutein modulators

#18
20200297716
2020-09-24

Therapeutic agent for fibrosis

#19
20200207737
2020-07-02

Somatostatin modulators and uses thereof

#20
20200157073
2020-05-21

Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof

#21
20200046718
2020-02-13

Theramutein modulators

#22
20200031775
2020-01-30

Substituted -arylethyl-2-arylquinoline-4-carboxamides and use thereof

#23
20200009128
2020-01-09

Therapeutic agent for fibrosis

#24
20190119200
2019-04-25

TERTIARY AMIDES AND METHOD OF USE

#25
20180289690
2018-10-11

Therapeutic agent for fibrosis

#26
20180042935
2018-02-15

Theramutein modulators

#27
20170217910
2017-08-03

INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES

#28
20160259242
2016-09-08

Onium salt compound, resist composition, and pattern forming process

#29
20160221921
2016-08-04

SKIN WHITENING AGENT CONTAINING NOVEL CYCLIC COMPOUND

#30
20150133441
2015-05-14

Theramutein modulators

#31
20150111886
2015-04-23

Adamantyl derivatives as cannabinoid receptor 2 agonists

#32
20150105376
2015-04-16

QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE

#33
20140378459
2014-12-25

Guanidinobenzoic acid compound

#34
20140364424
2014-12-11

Sulfonaminoquinoline hepcidin antagonists

#35
20140350045
2014-11-27

Phenoxyisobutyric acid compounds and method of synthesis

#36
20140243314
2014-08-28

Quinolinone carboxamide inhibitors of endothelial lipase

#37
20140235548
2014-08-21

COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION

#38
20130150358
2013-06-13

THERAMUTEIN MODULATORS

#39
20130108605
2013-05-02

METHOD OF AMELIORATING OXIDATIVE STRESS AND SUPPLEMENTING THE DIET

#40
20120302780
2012-11-29

AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS

#41
20120277265
2012-11-01

Polyquinoline derivatives and the therapeutic use thereof

#42
20120214803
2012-08-23

Novel Sulfonaminoquinoline Hepcidin Antagonists

#43
20120148955
2012-06-14

Resist composition, method of forming resist pattern, and new compound

#44
20120071502
2012-03-22

Novel phenoxyisobutyric acid compounds and methods for synthesis

#45
20120022057
2012-01-26

BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE

#46
20110319403
2011-12-29

Bicyclic compounds as inhibitors of diacylglycerol acyltransferase

#47
20110237776
2011-09-29

AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS

#48
20110237525
2011-09-29

Method of ameliorating oxidative stress and supplementing the diet

#49
20110207935
2011-08-25

Fused-ring derivative and medical application of same

#50
20100261758
2010-10-14

HETEROCYCLIC AMIDES FOR USE AS PHARMACEUTICALS

#51
20100228048
2010-09-09

Process for preparing substituted aromatic carboxylic acids

#52
20100222396
2010-09-02

4-ARYL-BUTANE-1,3-DIAMIDES

#53
20100216837
2010-08-26

GLYCINE TRANSPORT INHIBITORS

#54
20100075953
2010-03-25

SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS

#55
20100041656
2010-02-18

Amide derivatives and medicinal use thereof

#56
20100006805
2010-01-14

PROCESS FOR PRODUCTION OF BINUCLEAR METAL COMPLEX

#57
20090286828
2009-11-19

2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES

#58
20090253908
2009-10-08

NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS

#59
20090227626
2009-09-10

Polyquinoline derivatives and therapeutic use thereof

#60
20090076077
2009-03-19

Methods and Compositions for Selectin Inhibition

#61
20080269262
2008-10-30

Therameutin modulators

#62
20080262230
2008-10-23

Benzyloxypropylamine derivative

#63
20080255192
2008-10-16

Methods and Compositions for Selectin Inhibition

#64
20080242700
2008-10-02

Methods and Compositions for Selectin Inhibition

#65
20080076759
2008-03-27

Therapeutic Heterocyclic Compounds 507

#66
20080045568
2008-02-21

High affinity quinoline-based kinase ligands

#67
20070259882
2007-11-08

3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS

#68
20070197546
2007-08-23

QUINOLINE-4-CARBOXAMIDE AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS

#69
20070161697
2007-07-12

Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases

#70
20070161647
2007-07-12

QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS

#71
20060276515
2006-12-07

Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same

#72
20060241109
2006-10-26

PGD2 receptor antagonists for the treatment of inflammatory diseases

#73
20060229315
2006-10-12

3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists

#74
20060205735
2006-09-14

Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonists

#75
20060111368
2006-05-25

Phosphodiesterase inhibitor

#76
20060094789
2006-05-04

α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#77
20060079553
2006-04-13

Quinoline derivatives as glucokinase ligands

#78
20060069282
2006-03-30

Process for producing aromatic nitrile compound

#79
20060025404
2006-02-02

Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists

#80
20060020135
2006-01-26

Long chain aliphatic alcohol derivatives and methods of making and using same

#81
20060019947
2006-01-26

Therapeutic chromone compounds

#82
20060004063
2006-01-05

Inhibitors of HCV NS5B polymerase

#83
20050245523
2005-11-03

Heteroaryl derivatives and their use as medicaments

#84
20050209273
2005-09-22

Metabotropic glutamate receptor antagonists

#85
20050182050
2005-08-18

Therapeutic heterocyclic compounds

#86
20050176762
2005-08-11

Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists

#87
20050176744
2005-08-11

Heteroaryl derivatives and their use as medicaments

#88
20050171366
2005-08-04

Method of preparing intermediates useful in synthesis of retroviral protease inhibitors

#89
20050159428
2005-07-21

Quinoline-4-carboxamide derivatives asNK-2 and NK-3 receptor antagonists

#90
20050154202
2005-07-14

Substituted aryl amides

#91
20050101568
2005-05-12

Methods and compositions for selectin inhibition

#92
20050020584
2005-01-27

Benzamide derivatives as antagonists of orexin receptors

#93
20050009818
2005-01-13

Therapeutic heterocyclic compounds

#94
20050004167
2005-01-06

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases